1-4 of 4
C. Karlsson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ABT-737 Sensitizes B Cell Tumors for Killing by CD19-Retargeted T Cells,

Hannah S C Karlsson, Camilla Lindqvist, PhD, Gabriella Paul-Wetterberg, Helena Jernberg Wiklund, PhD, Kenneth Nilsson, MD, PhD, Bengt Simonsson, MD, PhD, Per Frisk, MD, PhD, Angelica Loskog, PhD
Journal: Blood
Blood (2011) 118 (21): 4032.
https://doi.org/10.1182/blood.V118.21.4032.4032
Published: 2011
Journal Articles

Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma

Signe Hässler, Chris Ramsey, Mikael C. Karlsson, Disa Larsson, Björn Herrmann, Björn Rozell, Magnus Backheden, Leena Peltonen, Olle Kämpe, Ola Winqvist
Journal: Blood
Blood (2006) 108 (6): 1941–1948.
https://doi.org/10.1182/blood-2006-04-019679
Published: 2006
Includes: Supplemental data
Journal Articles

Treatment of Refractory Autoimmune Hemolytic Anemia in B-CLL with Alemtuzumab (Humanized CD52 MAb).

Jeanette Lundin, F. Celsing, C. Karlsson, A. Osterborg
Journal: Blood
Blood (2005) 106 (11): 2967.
https://doi.org/10.1182/blood.V106.11.2967.2967
Published: 2005
Journal Articles

Virus Reactivation Profile as Assessed by PCR and Serology Pattern Following First-Line Alemtuzumab (Anti-CD52 Monoclonal Antibody, Campath®) Therapy in Patients with B-CLL.

C. Karlsson, H. Dahl, A. Linde, J. Lundin, M. Björkholm, H. Mellstedt, A. Osterborg
Journal: Blood
Blood (2004) 104 (11): 968.
https://doi.org/10.1182/blood.V104.11.968.968
Published: 2004